R25G mutation in exon 1 of LMNA gene is associated with dilated cardiomyopathy and limb-girdle muscular dystrophy 1B

被引:0
|
作者
YUAN WoliangHUANG ChunyanWANG JingfengXIE ShuanglunNIE RuqiongLIU YingmeiLIU PinmingZHOU ShuxianCHEN Suqin and HUANG Weijun Department of Cardiovascular MedicineSecond Affiliated Hospital of Sun Yatsen UniversityGuangzhouGuangdong China Department of GeneticsSun Yatsen UniversityGuangzhouGuangdong China [510120 ,510089 ]
机构
关键词
D O I
暂无
中图分类号
R686 [筋腱、韧带、滑囊疾病及损伤];
学科分类号
摘要
Background Mutations of the LMNA gene encoding lamin A and C are associated with dilated cardiomyopathy (DCM),conduction system defects and skeletal muscle dystrophy. Here we report a family with a mutation of the LMNA gene toidentify the relationship between genotype and phenotype.Methods All 30 members of the family underwent clinical and genetic evaluation. A mutation analysis of the LMNAgene was performed. All of the 12 exons of LMNA gene were extended with polymerase chain reaction (PCR) and thePCR products were screened for gene mutation by direct sequencing.Results Ten members of the family had limb-girdle muscular dystrophy (LGMD) and 6 are still alive. Two patientssuffered from DCM. Cardiac arrhythmias included atrioventricular block and atrial fibrillation; sudden death occurred in 2patients. The pattern of inheritance was autosomal dominant. Mutation c.73C>G (R25G) in exon 1 encoding the globulardomains was confirmed in all of the affected members, resulting in the conversion of arginine (Arg) to glycine (Gly).Conclusions The mutation R25G in exon 1 of LMNA gene we reported here in a Chinese family had a phenotype ofmalignant arrhythmia and mild LGMD, suggesting that patients with familial DCM, conduction system defects and skeletalmuscle dystrophy should be screened by genetic testing for the LMNA gene.
引用
收藏
页码:2840 / 2845
相关论文
共 50 条
  • [41] Genetically confirmed limb-girdle muscular dystrophy type 2B with DYSF mutation using gene panel sequencing A case report
    Lee, Sook Joung
    Choi, Eunseok
    Shin, Soyoung
    Park, Joonhong
    MEDICINE, 2020, 99 (28) : E20810
  • [42] Development of an iPSC-Derived Cell Therapy for Limb-Girdle Muscular Dystrophy Type 2A/R1
    Sun, Congshan
    Barber, Casey
    Coleman, Andrew
    Safairad, Oscar
    Jacob, Sheela
    Saberi, Amir
    Ren, Luke
    Wesa, Amy
    Alexandra, Capela
    Falk, Douglas
    Andersen, Peter
    MOLECULAR THERAPY, 2023, 31 (04) : 434 - 434
  • [43] Computed tomography with color reconstruction in a group of R9 limb-girdle muscular dystrophy patients with c.1387A>G mutation
    Escobar Cedillo, R.
    Martinez Coria, E.
    Miranda Duarte, A.
    Malfatti, E.
    Gomez Diaz, B.
    Luna Angulo, A.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S120 - S120
  • [44] Segmental Uniparental Isodisomy Causing an "Inside-to-Outside" Limb-Girdle Muscular Dystrophy Due to a Homozygous Mutation in POGLUT1
    Ghaoui, Roula
    Curtis, Samuel
    Kassahn, Karin S. S.
    JAMA NEUROLOGY, 2023, 80 (08) : 868 - 869
  • [45] Muscle-specific Ryanodine receptor 1 properties underlie limb-girdle muscular dystrophy 2B/R2 progression
    Meizoso-Huesca, Aldo
    Lamboley, Cedric R.
    Krycer, James R.
    Hodson, Mark P.
    Hudson, James E.
    Launikonis, Bradley S.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [46] Two Korean Families with Limb-Girdle Muscular Dystrophy Type 1D Associated with DNAJB6 Mutations
    Kim, Kitae
    Park, Hyung Jun
    Lee, Jung Hwan
    Hong, Jiman
    Ahn, Suk-Won
    Choi, Young-Chul
    YONSEI MEDICAL JOURNAL, 2018, 59 (05) : 698 - 701
  • [47] A slowly progressive form of limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics
    Al-Zaidy, Samiah A.
    Malik, Vinod
    Kneile, Kelley
    Rosales, Xiomara Q.
    Gomez, Ana Maria
    Lewis, Sarah
    Hashimoto, Sayaka
    Gastier-Foster, Julie
    Kang, Peter
    Darras, Basil
    Kunkel, Louis
    Carlo, Jose
    Sahenk, Zarife
    Moore, Steven A.
    Pyatt, Robert
    Mendell, Jerry R.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2015, 3 (02): : 92 - 98
  • [48] Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results
    Mendell, Jerry R.
    Pozsgai, Eric R.
    Lewis, Sarah
    Griffin, Danielle A.
    Lowes, Linda P.
    Alfano, Lindsay N.
    Lehman, Kelly J.
    Church, Kathleen
    Reash, Natalie F.
    Iammarino, Megan A.
    Sabo, Brenna
    Potter, Rachael
    Neuhaus, Sarah
    Li, Xiaoxi
    Stevenson, Herb
    Rodino-Klapac, Louise R.
    NATURE MEDICINE, 2024, 30 (01) : 199 - +
  • [49] Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results
    Jerry R. Mendell
    Eric R. Pozsgai
    Sarah Lewis
    Danielle A. Griffin
    Linda P. Lowes
    Lindsay N. Alfano
    Kelly J. Lehman
    Kathleen Church
    Natalie F. Reash
    Megan A. Iammarino
    Brenna Sabo
    Rachael Potter
    Sarah Neuhaus
    Xiaoxi Li
    Herb Stevenson
    Louise R. Rodino-Klapac
    Nature Medicine, 2024, 30 : 199 - 206
  • [50] Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results
    Mendell, Jerry R.
    Pozsgai, Eric R.
    Lewis, Sarah
    Griffin, Danielle A.
    Lowes, Linda P.
    Alfano, Lindsay N.
    Lehman, Kelly J.
    Church, Kathleen
    Reash, Natalie F.
    Iammarino, Megan A.
    Sabo, Brenna
    Potter, Rachael
    Neuhaus, Sarah
    Li, Xiaoxi
    Stevenson, Herb
    Rodino-Klapac, Louise R.
    NATURE MEDICINE, 2024, 30 (01) : 199 - +